SCHOTT Pharma AG & Co. KGaA - Neraca (Quarterly)

SCHOTT Pharma AG & Co. KGaA
AT ˙ WBAG ˙ DE000A3ENQ51
€ 26.65 ↑1.15 (4.51%)
2025-07-10
BAHAGING PRESYO
Talaan ng Balanse (Quarterly)

Neraca SCHOTT Pharma AG & Co. KGaA menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2021
09-30
2022
09-30
2023
06-30
2023
09-30
2023
12-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 19 28 29 21 24 21 22 23 17 26 28
Change (%) 49.73 3.36 -27.42 16.54 -12.39 3.81 4.64 -27.62 55.51 8.42
Assets Current 239 302 555 465 468 465 586 589 614 612 648
Change (%) 26.44 83.52 -16.06 0.62 -0.66 25.95 0.45 4.34 -0.37 5.97
Assets 596 740 1,196 1,153 1,232 1,241 1,399 1,442 1,480 1,486 1,528
Change (%) 24.14 61.71 -3.63 6.83 0.77 12.70 3.09 2.59 0.41 2.86
Liabilities 280 320 487 502 540 520 630 650 648 647 663
Change (%) 14.31 52.10 2.97 7.51 -3.61 21.06 3.22 -0.30 -0.18 2.51
Equity 316 419 709 651 692 721 769 792 832 839 865
Change (%) 32.87 69.05 -8.17 6.31 4.19 6.67 2.99 4.96 0.87 3.12
Liabilities And Stock Equity 596 740 1,196 1,153 1,232 1,241 1,399 1,442 1,480 1,486 1,528
Change (%) 24.14 61.71 -3.63 6.83 0.77 12.70 3.09 2.59 0.41 2.86

Source: Capital IQ

Other Listings
IT:1SXP € 26.55
DE:1SXP € 22.00
GB:1SXPD
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista